Kevin Lustig, CEO of Assay Depot Inc., said the company has forged deals with two of the top 10 drug companies.

Kevin Lustig, CEO of Assay Depot Inc., said the company has forged deals with two of the top 10 drug companies. Photo by Melissa Jacobs.

Making a drug used to fall to Big Pharma, costing a billion dollars and requiring resources and lab space to boot...